Clinical Trial Update: Gem-TABS in Unresectable Pancreatic Carcinoma [Phase 1]

View source ↗

Summary

This document reports a completed Phase 1 trial of Gem-TABS for unresectable pancreatic cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Gem-TABS

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Pancreatic Cancer | Phase 1 | Status: COMPLETED